SCHEMBL15340734

SCHEMBL15340734

CO/N=C1/c2ccccc2CCCC1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.36
HPGD P15428 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CYP2A6 P11509 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
MAPT P10636 4/20 0.34
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
IDO1 P14902 2/20 0.34
MEN1 O00255 1/20 0.34
PLA2G1B P04054 1/20 0.34
KMT2A Q03164 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
GID4 Q8IVV7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15079060 0.71 HTT (0.40) LMNAL3MBTL1HPGDALDH1A1CYP2A6
SCHEMBL16263341 0.70 CYP2A6 (0.41) LMNAL3MBTL1HPGDALDH1A1CYP2A6
SCHEMBL17190983 0.70 ALDH1A1 (0.56) LMNAL3MBTL1HPGDALDH1A1CYP2A6
SCHEMBL17190976 0.70 L3MBTL1 (0.59) LMNAL3MBTL1HPGDALDH1A1MAPT
SCHEMBL12500873 0.70 CYP2A6 (0.50) ALDH1A1CYP2A6MAOAMAOBMAPT
SCHEMBL13167840 0.70 ALDH1A1 (0.56) LMNAL3MBTL1HPGDALDH1A1CYP2A6
SCHEMBL25890369 0.69 ACHE (0.50) LMNA
SCHEMBL788630 0.66 SMN1; SMN2 (0.46) LMNAL3MBTL1HPGDALDH1A1MAPT
SCHEMBL11886413 0.66 SMN1; SMN2 (0.46) LMNAL3MBTL1HPGDALDH1A1MAPT
SCHEMBL10192543 0.66 SMN1; SMN2 (0.46) LMNAL3MBTL1HPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2661426-B1 PYRAZOL-4-YL CARBOXAMIDE DERIVATIVES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2014-08-27 EP disclosed
US-8653003-B2 Pyrazol-4-yl carboxamide derivatives as microbiocides SYNGENTA PARTICIPATIONS AG (CH) 2014-02-18 US disclosed
US-8653003-B2 Pyrazol-4-yl carboxamide derivatives as microbiocides SYNGENTA PARTICIPATIONS AG (CH) 2014-02-18 US disclosed
US-20130281505-A1 PYRAZOL-4-YL CARBOXAMIDE DERIVATIVES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2013-10-24 US disclosed
US-20130281505-A1 PYRAZOL-4-YL CARBOXAMIDE DERIVATIVES AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2013-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281505-A1 PYRAZOL-4-YL CARBOXAMIDE DERIVATIVES AS MICROBIOCIDES C3AR1, CD209, CCR9 LMNA 3819/4885L3MBTL1 432/4885HPGD 1009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.